Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder IPF

Boehringer Ingelheim’s Jascayd blocks a protein involved in the lung inflammation that develops from idiopathic pulmonary fibrosis, a rare and ultimately fatal disease with few available therapies. The twice-daily pill doesn’t cure IPF but clinical trial results showed it slowed disease progression. The post Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder…

Read More

How Are Healthcare Leaders Tackling Automation Bias?

At MedCity News’ INVEST Digital Health conference, healthcare experts explored strategies to mitigate automation bias — emphasizing the importance of vendor responsibility, use case-specific governance and clinician engagement. The post How Are Healthcare Leaders Tackling Automation Bias? appeared first on MedCity News.

Read More

Shirley Ryan AbilityLab Earns New Joint Commission Sustainability Award

Shirley Ryan AbilityLab Earns New Joint Commission Sustainability Award  With support from Compass One Healthcare, Shirley Ryan AbilityLab has reached another milestone in its commitment to environmental stewardship.  The Chicago-based rehabilitation hospital, renowned for treating patients with stroke, spinal cord, and brain injuries, has earned The Joint Commission’s new Sustainability Healthcare Certification. It is the…

Read More

White House AI Action Plan: What Healthcare Leaders Must Do Now

Healthcare and life sciences are about to face unprecedented AI-driven regulatory changes that will reshape everything from research and development to drug approval submissions. Here are 10 steps healthcare and life sciences organizations should take to strategically prepare. The post White House AI Action Plan: What Healthcare Leaders Must Do Now appeared first on MedCity…

Read More